Arrowhead, Sarepta Launch On A Whopping $11.38 Billion Deal - Investor's Business Daily

The deal focuses on four clinical-stage drugs, three preclinical assets and a potential five new targets.

By: Investor's Business Daily

Nov 28 2024
0
0 Views

Shares of Arrowhead Pharmaceuticals (ARWR) catapulted Tuesday after the company inked a broad licensing deal with Sarepta Therapeutics (SRPT) for an array of gene-silencing products. XNOW PLAYINGBio… [+2691 chars]

Dell Stock Tumbles As Sales Miss Estimates Despite 'Robust' AI Opportunity - Investor's Business Daily

EV maker Rivian gets $6.6 billion federal loan to finish Georgia plant - The Washington Post

Could Elon Musk X-ify MSNBC? Don’t Bet On It - Hollywood Reporter

United blames FAA staffing shortages for causing ‘significant disruption’ at Newark Airport - New York Post

Constellation Brands' stock falls as Trump tariff plan threatens to make Modelo and Corona more expensive - CNBC

Small business owners breathe easier over labor costs after decision to strike down overtime rule - The Associated Press

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network